Freemelt reports preliminary 2024 results
January 27, 2025

Freemelt AB, based in Mölndal, Sweden, has shared its preliminary figures for the fourth quarter of 2024, which saw net sales of €714,728, up from €662,489 in the previous year. During the quarter, a Freemelt ONE machine was delivered to a leading research institute in the US.
“During 2024, we have made significant progress in our strategy to combine innovation with commercialisation,” stated Freemelt CEO Daniel Gidlund. “Through successful collaborations with research institutes and universities, we have continued to drive innovation while strengthening our relationships with industrial users to meet their development needs and future production demands. These collaborations have not only helped to transition applications from concept to serial production but have also resulted in increased order volumes and new revenue streams.”
The preliminary net sales for the full-year net sales totalled €1,743,460 (€1,944,047). The orderbook at year-end amounted to €1,080,885 (€156,903). At year-end, the company’s cash position was €1,446,972 (€2,972,395.) The balance includes currency gains of €8,717 on bank balances in foreign currency.
Gidlund continued, “We have initiated over twenty paid development projects with potential end customers during the year, most of which have been feasibility studies within the defence and energy sectors. We have successfully completed twelve of these projects, while the others are progressing according to plan. This demonstrates a clear acceleration compared to the previous year, when we initiated a total of three feasibility studies with potential end customers and reflects the market needs for our innovative technology. One of the year’s most prestigious achievements was our collaboration with Saab on defence applications, further confirming the value our E-PBF (Electron Beam Powder Bed Fusion) technology brings to the development of high-performance, complex solutions.
“Two years ago, we introduced our industrial eMELT series concept at Formnext, and this past summer, we delivered our first machine to an industrial customer in Italy,” he added. “The machine will be used to accelerate the adoption of 3D printing as a manufacturing method for serial production of industrial applications. Additionally, during the autumn, we secured two strategic agreements with global OEMs (Original Equipment Manufacturer) for proof-of-concept projects using eMELT for serial production of orthopaedic implants, positioning us strongly for future large-scale deliveries of eMELT.”